1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow vorasidenib: new trials by email Literature Review of vorasidenib trials Research Report on vorasidenib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation Vorasidenib - Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation | Phase 2 | Recruiting | Institut de Recherches Internationales Servier (I.R.I.S.) | 10 | 2026-07-23 | 2026-09-08 |
| Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma Vorasidenib, Temozolomide (TMZ) - IDH1-mutant Glioma, IDH2-mutant Glioma | Phase 1 / Phase 2 | Active not recruiting | Institut de Recherches Internationales Servier | 51 | 2025-01-22 | 2026-07-08 |
Institut de Recherches Internationales Servier (1) · Institut de Recherches Internationales Servier (I.R.I.S.) (1)
United States (2) · Australia (1) · Austria (1) · China (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United Kingdom (1)